These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27338131)

  • 41. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
    Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
    Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles.
    Ghanbarzadeh S; Hariri R; Kouhsoltani M; Shokri J; Javadzadeh Y; Hamishehkar H
    Colloids Surf B Biointerfaces; 2015 Dec; 136():1004-10. PubMed ID: 26579567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
    Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and in vitro and in vivo evaluations of poly(ethylene glycol)-block-poly(4-vinylbenzylphosphonate) magnetic nanoparticles containing doxorubicin as a potential targeted drug delivery system.
    Hałupka-Bryl M; Asai K; Thangavel S; Bednarowicz M; Krzyminiewski R; Nagasaki Y
    Colloids Surf B Biointerfaces; 2014 Jun; 118():140-7. PubMed ID: 24769390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.
    Khallaf RA; Salem HF; Abdelbary A
    Drug Deliv; 2016 Nov; 23(9):3452-3460. PubMed ID: 27240935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.
    Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z
    Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
    Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Etoposide loaded solid lipid nanoparticles for curtailing B16F10 melanoma colonization in lung.
    Athawale RB; Jain DS; Singh KK; Gude RP
    Biomed Pharmacother; 2014 Mar; 68(2):231-40. PubMed ID: 24560352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
    Mahmud A; Xiong XB; Lavasanifar A
    Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.
    Hu G; Chun X; Wang Y; He Q; Gao H
    Oncotarget; 2015 Dec; 6(38):41258-74. PubMed ID: 26517810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells.
    Kuo YC; Liang CT
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):131-7. PubMed ID: 21411296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of nitrosyl ruthenium complex-loaded lipid carriers for topical administration: improvement in skin stability and in nitric oxide release by visible light irradiation.
    Marquele-Oliveira F; Santana DC; Taveira SF; Vermeulen DM; de Oliveira AR; da Silva RS; Lopez RF
    J Pharm Biomed Anal; 2010 Dec; 53(4):843-51. PubMed ID: 20634015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbon nanoparticles suspension injection for the delivery of doxorubicin: Comparable efficacy and reduced toxicity.
    Huang Y; Xie P; Yang ST; Zhang X; Zeng G; Xin Q; Tang XH
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():416-423. PubMed ID: 30184767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
    Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
    Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo.
    Al-Jamal KT; Al-Jamal WT; Wang JT; Rubio N; Buddle J; Gathercole D; Zloh M; Kostarelos K
    ACS Nano; 2013 Mar; 7(3):1905-17. PubMed ID: 23527750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Augmented anticancer efficacy of doxorubicin-loaded polymeric nanoparticles after oral administration in a breast cancer induced animal model.
    Jain AK; Swarnakar NK; Das M; Godugu C; Singh RP; Rao PR; Jain S
    Mol Pharm; 2011 Aug; 8(4):1140-51. PubMed ID: 21557558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acid-sensitive lipidated doxorubicin prodrug entrapped in nanoemulsion impairs lung tumor metastasis in a breast cancer model.
    Dos Santos Câmara AL; Nagel G; Tschiche HR; Cardador CM; Muehlmann LA; de Oliveira DM; Alvim PQ; Azevedo RB; Calderón M; Figueiró Longo JP
    Nanomedicine (Lond); 2017 Aug; 12(15):1751-1765. PubMed ID: 28703043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer.
    Choi SH; Byeon HJ; Choi JS; Thao L; Kim I; Lee ES; Shin BS; Lee KC; Youn YS
    J Control Release; 2015 Jan; 197():199-207. PubMed ID: 25445703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.